About Progenics
Progenics is a company based in United States founded in 1988 was acquired by Lantheus in October 2019.. The company has 53 employees as of December 31, 2020. Progenics has completed 3 acquisitions, including AZEDRA, EXINI Diagnostics and Molecular Insight Pharmaceuticals. Progenics operates in a competitive market with competitors including ImaginAb, MDxHealth, AC Immune, GenomeDx Biosciences and APRINOIA, among others.
- Headquarter United States
- Employees 53 as on 31 Dec, 2020
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Progenics Pharmaceuticals, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Progenics
- Total Funding Total Funding
- Total Rounds 8
- Last Round Post-IPO — $12.9M
-
First Round
First Round
(01 Jan 2006)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2013 | Amount | Post-IPO - Progenics | Valuation |
investors |
|
| May, 2011 | Amount | Grant - Progenics | Valuation |
investors |
|
| Sep, 2010 | Amount | Grant - Progenics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Progenics
Progenics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Lantheus. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Developer of diagnostic imaging agents and targeted therapeutics
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Progenics
Progenics has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include AZEDRA, EXINI Diagnostics and Molecular Insight Pharmaceuticals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapy for pheochromocytoma and paraganglioma diseases is provided.
|
2006 | ||||
|
Artificial neural networks are applied to medical scan diagnostics.
|
1999 | ||||
|
Radiopharmaceuticals and molecular imaging agents for use in oncology
|
1997 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Progenics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Progenics Comparisons
Competitors of Progenics
Progenics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ImaginAb, MDxHealth, AC Immune, GenomeDx Biosciences and APRINOIA, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| domain | founded_year | HQ Location |
Epigenetic tests for personalized cancer assessment and treatment.
|
|
| domain | founded_year | HQ Location |
Antibodies, small molecules, and vaccines are developed for neurodegenerative diseases.
|
|
| domain | founded_year | HQ Location |
Genomic tests for urologic cancers are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Diagnostics and therapeutics for neurodegenerative disorders are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule drugs and imaging agent for GI disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Progenics
Frequently Asked Questions about Progenics
When was Progenics founded?
Progenics was founded in 1988 and raised its 1st funding round 18 years after it was founded.
Where is Progenics located?
Progenics is headquartered in United States.
How many employees does Progenics have?
As of Dec 31, 2020, the latest employee count at Progenics is 53.
What does Progenics do?
Progenics Pharmaceuticals was founded in 1988 in the United States and operates in the oncology sector of pharmaceuticals. Imaging agents and targeted radiotherapeutics are developed, focusing on prostate-specific membrane antigen (PSMA)-targeted technologies for prostate cancer, including antibody drug conjugates and small molecule agents. Additional pipeline assets include Azedra for malignant pheochromocytoma and paraganglioma treatment. The first commercial product, Relistor, is approved for opioid-induced constipation.
Who are the top competitors of Progenics?
How many acquisitions has Progenics made?
Progenics has made 3 acquisitions, including AZEDRA, EXINI Diagnostics, and Molecular Insight Pharmaceuticals.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.